Stericycle

Stericycle, Inc. engages in the provision of waste management services. It operates through the following segments: North America and International. The North America and International segments offer the following services: Regulated Waste and Compliance Services (RWCS), Secure Information Destruction Services (SID), Communication and Related Services (CRS). The RWCS provides collection and processing of regulated and specialized waste, including medical (including reusable sharps disposal management services), pharmaceutical and hazardous waste, for disposal and compliance programs. The SID provides a collection of personal and confidential information for secure destruction and recycling of shredded paper. The CRS includes communication services such as appointment reminders, secure messaging, event registration and other communications for hospitals and IDN’s. The company was founded by James W. Sharp in March 1989 and is headquartered in Lake Forest, IL.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Stericycle reports robust Q4 performance and outlines growth strategies

Stericycle's Q4 2022 showcased strong financial performance and strategic initiatives for growth and efficiency.
Guidance for 2023 outlines organic revenue growth, adjusted EPS range, and debt reduction targets, positioning the company for continued success.
Despite challenges from ERP rollout impact and macroeconomic factors, Stericycle's focus on operational improvements and revenue growth presents opportunities for long-term value creation.

Stericycle reports robust Q1 performance, eyes growth amid challenges

Stericycle's Q1 performance reflects strong revenue growth and margin expansion, supported by operational efficiency and strategic divestitures.
While facing challenges such as inflation impacts and debt management, the company is well-positioned to capitalize on opportunities like capital deployment and revenue growth drivers.
Overall, Stericycle's focus on operational excellence, financial discipline, and strategic investments sets a positive trajectory for sustainable growth and profitability.

Stericycle achieves debt reduction targets amidst revenue growth challenges

Stericycle's Q2 performance reflects progress in debt reduction, operational efficiency, and revenue growth despite challenges in certain segments.
Strategic divestments, infrastructure projects, and commitment to guidance demonstrate resilience and adaptability in a changing market landscape.
Addressing challenges in Secure Information Destruction and ERP implementation while capitalizing on opportunities for further divestments and operational improvements will be key for future success.

Stericycle reports positive Q3 earnings, eyes ERP enhancements for growth

Stericycle's Q3 performance showcased growth in regulated waste services and adjustments in financial guidance.
The company's focus on ERP enhancements, legacy system optimization, and workforce reductions positions it for future success.
Challenges in Secure Information Destruction revenue and national account impacts are being addressed for long-term growth.
Opportunities lie in improving operational efficiency, customer engagement, and capitalizing on stable national account trends.

Stericycle reports solid Q4 performance, eyes growth through acquisitions

Stericycle's Q4 2023 performance showcased revenue growth, margin expansion, and operational efficiency efforts, driving a focus on profitable growth and financial discipline.
The company's strengths lie in ESG initiatives, regional positioning, technology utilization, and construction progress, offering a foundation for strategic growth and sustainability.
Challenges include cash flow impacts, analyst inquiries, portfolio optimization hurdles, and market headwinds, which Stericycle aims to address through strategic planning and execution.
Opportunities for Stericycle include organic revenue growth, acquisitions, cash flow optimization, and operational enhancements, positioning the company for continued success and resilience.

Stericycle reports improved Q1 earnings amidst pricing challenges and growth opportunities

Stericycle's Q1 2024 showcased improved financial performance driven by revenue growth in key segments, despite challenges from pricing headwinds and commodity indexed revenues.
The company's focus on workforce optimization, operational enhancements, and a transition to a subscription-based model presents growth opportunities and margin expansion potential.
While facing challenges in certain revenue streams, Stericycle's strategic initiatives and commitment to diversity and inclusion position it well for future growth and profitability.
Overall, Stericycle's Q1 performance reflects a balanced approach to addressing challenges, leveraging strengths, and capitalizing on opportunities for sustained growth and success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Stericycle provides healthcare organizations and businesses with waste services. The company specializes in medical waste disposal, secure document destruction, and compliance solutions. Stericycle helps organizations manage waste and information securely and protects public health and the environment.

Shoreline restoration projects will help preserve and protect critical habitats and recreational spaces at two national park sites for generations to come. BANNOCKBURN, Ill.

Stericycle Partners with the National Park Foundation to Help Restore Shorelines in Florida and Georgia

Stericycle Communication Solutions' Third Annual Patient Engagement Survey Reveals Current Patient Preferences for Access and Convenience

Annual award recognizes top IT executives in the Chicagoland area  BANNOCKBURN, Ill. , Oct. 20, 2022 /PRNewswire/ -- Stericycle, Inc. (Nasdaq: SRCL), a leading provider of regulated medical waste management, secure information destruction and patient engagement solutions, today announced Janet Zelenka, chief financial officer and chief information officer, has received the 2022 CIO+ award from The Executives' Club of Chicago, The Society of Information Management (SIM) Chicago and The Association of Information Technology Professionals (AITP) Chicago.

Stericycle CFO and CIO Janet Zelenka Receives 2022 CIO+ Award from The Executives' Club of Chicago, SIM Chicago and AITP Chicago

Company highlights progress on environmental transparency and contributions to a more diverse, equitable, inclusive and sustainable future BANNOCKBURN, Ill. , Oct. 19, 2022 /PRNewswire/ -- Stericycle, Inc. (Nasdaq: SRCL), a leading provider of medical waste management, secure information destruction and patient engagement solutions, today published its 2022 Corporate Social Responsibility (CSR) report, which highlights the company's continued progress in conducting business safely, responsibly and sustainably while advancing its strategic Environmental, Social and Governance (ESG) initiatives.

Stericycle Publishes Annual Corporate Social Responsibility Report

BANNOCKBURN, Ill., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today announced that Cindy J. Miller, Chief Executive Officer, and Janet Zelenka, Chief Financial Officer and Chief Information Officer, will present at the Baird 2022 Global Industrial Conference in Chicago on Tuesday, November 8, 2022, and will participate in meetings with investors throughout the day.

Stericycle to Present at Baird 2022 Global Industrial Conference in November

Stericycle's revenue outlook is murky, the recovery for the secure information destruction business is still in progress, but the regulated waste and compliance segment might be affected by staffing shortages. SRCL should still record lower earnings for FY 2022 vis-a-vis FY 2021 despite delivering an EPS beat in Q2, due to higher operating and interest expenses.

Stericycle: Muted Outlook, Fair Valuations

Nine in 10 small business leaders find it harder than ever to keep their company's data and information safe. BANNOCKBURN, Ill.

Shred-it Annual Report Finds Data Protection Vital for Small Businesses

Quest Resource Hld

QRHC vs. SRCL: Which Stock Is the Better Value Option?

QRHC or SRCL: Which Is the Better Value Stock Right Now?

Stericycle, Inc. (NASDAQ:SRCL ) Q2 2022 Earnings Conference Call August 5, 2022 9:00 AM ET Company Participants Andrew Ellis - Vice President of Investor Relations Cindy Miller - President & Chief Executive Officer Janet Zelenka - Executive Vice President, Chief Financial Officer & Chief Information Officer Conference Call Participants Michael Hoffman - Stifel Sean Dodge - RBC Capital Markets David Manthey - Baird Operator Hello everyone and welcome to the Stericycle Second Quarter 2022 Earnings Call. My name is Stacy, and I'll be coordinating today's call.

Stericycle, Inc. (SRCL) CEO Cindy Miller on Q2 2022 Results - Earnings Call Transcript

Stericycle (SRCL) delivered earnings and revenue surprises of 11.63% and 1.55%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Stericycle (SRCL) Surpasses Q2 Earnings and Revenue Estimates

BANNOCKBURN, Ill., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the second quarter ended June 30, 2022.

Stericycle, Inc. Reports Results For the Second Quarter 2022

Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Stericycle (SRCL) to Report a Decline in Earnings: What to Look Out for

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Stericycle, Inc. (“Stericycle” or the “Company”) (NASDAQ: SRCL) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Stericycle investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securitie

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Stericycle, Inc. (SRCL) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Stericycle, Inc. (“Stericycle” or the “Company”) (NASDAQ: SRCL) investors concerning the Company's possible violations of federal securities laws. On April 20, 2022, it was announced that Stericycle had agreed to pay over $84 million to resolve investigations by U.S. and Brazilian regulators regarding the bribery of officials in multiple countries between 2011 and 2016. On this news, Stericycl

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Stericycle, Inc. (SRCL) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Stericycle, Inc. (“Stericycle” or the “Company”) (NASDAQ: SRCL) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On April 20, 2022, it was announced that Stericycle had agreed to pay over $84 million to resolve investigations by U.S. and Brazilian regulators regarding the bribery of of

The Law Offices of Frank R. Cruz Announces Investigation of Stericycle, Inc. (SRCL) on Behalf of Investors

QRHC vs. SRCL: Which Stock Should Value Investors Buy Now?

Los Angeles, California--(Newsfile Corp. - July 8, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Stericycle, Inc. ("Stericycle" or "the Company") (NASDAQ: SRCL) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. It was announced on April 20, 2022, that Stericycle agreed to pay...

ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Stericycle, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - July 7, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Stericycle, Inc. ("Stericycle" or "the Company") (NASDAQ: SRCL) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. It was announced on April 20, 2022, that Stericycle agreed to pay...

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Stericycle, Inc. with Losses of $100,000 to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, reminds investors it is investigating whether certain directors and officers of Stericyle, Inc. (“Stericycle”) (NASDAQ: SRCL) breached their fiduciary duties to Stericycle and its shareholders. If you are a Stericycle shareholder, you are encouraged to contact attorney Joe Pettigrew with Scott+Scott for additional information at (844) 818-6982 or jpettigrew@sco

STERICYCLE, INC. INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Stericycle, Inc.'s Directors and Officers for Breach of Fiduciary Duties – SRCL

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of Stericycle, Inc. (“Stericycle”) (NASDAQ: SRCL) breached their fiduciary duties to Stericycle and its shareholders. If you are a Stericycle shareholder, you are encouraged to contact attorney Joe Pettigrew with Scott+Scott for additional information at (844) 818-6982 or jpettigrew@scott-scott.com. Scott+

INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Stericycle, Inc.'s Directors and Officers for Breach of Fiduciary Duties – SRCL

- Annual ORBIE Awards recognize top technology executives for leadership, innovation and excellence - BANNOCKBURN, Ill. , May 23, 2022 /PRNewswire/ -- Stericycle, Inc. (Nasdaq: SRCL) a leading provider of medical waste, secure information destruction and patient engagement solutions, today announced Janet Zelenka, chief financial officer and chief information officer, has been named a Chicago CIO of the Year® ORBIE® award winner in the Enterprise category.

Stericycle's Janet Zelenka Wins Prestigious 2022 Chicago CIO of the Year® ORBIE® Award

BANNOCKBURN, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today announced that Janet Zelenka, Chief Financial Officer and Chief Information Officer, and Andrew Ellis, Vice President of Investor Relations, will participate in a fireside chat and investor meetings at the Jefferies Healthcare Conference in New York on Wednesday, June 8, 2022.

Stericycle to Participate in Jefferies Healthcare Conference in June

The Company's partnership reaffirms its commitment to supporting the circular economy by restoring forests in the United States, Canada and the United Kingdom BANNOCKBURN, Ill. , May 12, 2022 /PRNewswire/ -- Stericycle, Inc. (Nasdaq: SRCL), a leading provider of regulated medical waste management, secure information destruction and patient engagement solutions, today announced a $100,000, one-year partnership with the Arbor Day Foundation.

Stericycle Commits $100,000 to the Arbor Day Foundation to Replant Trees and Help Make the World Greener and Healthier

BANNOCKBURN, Ill., May 06, 2022 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today announced that Janet Zelenka, Chief Financial Officer and Chief Information Officer, and Andrew Ellis, Vice President of Investor Relations, will participate in a fireside chat and investor meetings at the Stifel 2022 Cross Sector Insight Conference in Boston on Thursday, June 9, 2022.

News for Stericycle Stock (SRCL)